An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels

Thies Rösner, Stefanie Derer*, Christian Kellner, Michael Dechant, Stefan Lohse, Gestur Vidarsson, Matthias Peipp, Thomas Valerius

*Corresponding author for this work
18 Citations (Scopus)
Original languageEnglish
JournalBritish Journal of Haematology
Issue number2
Pages (from-to)282-286
Number of pages5
Publication statusPublished - 04.2013

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Cite this